MARKET

NUVB

NUVB

Nuvation Bio Inc
NYSE
5.74
+0.01
+0.17%
After Hours: 5.81 +0.07 +1.22% 19:38 09/25 EDT
OPEN
5.73
PREV CLOSE
5.73
HIGH
5.83
LOW
5.67
VOLUME
2.82M
TURNOVER
--
52 WEEK HIGH
9.75
52 WEEK LOW
2.990
MARKET CAP
2.02B
P/E (TTM)
-13.1924
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at NUVB last week (0914-0918)?
Weekly Report · 6d ago
What Nuvation Bio (NUVB)'s Updated Cancer Drug Label Means For Shareholders
Simply Wall St · 09/20 11:19
Weekly Buzz: RARE, BAYRY Win Approvals; SION Cuts Jobs, GSK Deals; AZN, RHHBY Lead
NASDAQ · 09/18 14:44
5 Undervalued Oncology Stocks Wall Street Is Overlooking
Seeking Alpha · 09/18 13:22
NUVB Makes Bullish Cross Above Critical Moving Average
NASDAQ · 09/17 20:23
Why Is Nuvation Bio Stock Gaining Thursday?
Benzinga · 09/17 16:46
Nuvation Bio Wins FDA Nod For Updated IBTROZI Label Showing 50-Month DOR In ROS1+ Lung Cancer
NASDAQ · 09/17 13:02
Nuvation Bio rises on FDA label update for Ibtrozi
Seeking Alpha · 09/17 12:32
More
About NUVB
Nuvation Bio Inc. is a global oncology company. The Company is focused on tackling cancer treatment. Its diverse pipeline includes taletrectinib (IBTROZI), a next-generation ROS1 inhibitor; safusidenib, a brain-penetrant IDH1 inhibitor, and a drug-drug conjugate (DDC) program. IBTROZI is an oral, potent, central nervous system-active, selective, next-generation ROS1 inhibitor. Safusidenib is a novel, oral, potent, brain penetrant, targeted inhibitor of mutant isocitrate dehydrogenase 1 (mIDH1), which is detected in various tumors, including gliomas. Its platform leverages its drug discovery and chemistry expertise to find the minimum target binding sites of drug X and drug Y and fuse them together, while maintaining activity. Its DDCs are designed to selectively bind to intracellular as well as surface cell membrane targets that are expressed more highly in specific target tissues and to potently deliver anti-cancer warheads to these target tissues.

Webull offers Nuvation Bio Inc stock information, including NYSE: NUVB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NUVB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NUVB stock methods without spending real money on the virtual paper trading platform.